|
Realtime
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.6700 NOK | +2.29% |
|
-7.59% | -51.45% |
| 30.06. | Exact Therapeutics wird im Oktober von Euronext Growth Oslo genommen | MT |
| 26.06. | Exact Therapeutics AS erhält positive Sicherheitsbewertung für 60 µl/kg-Dosis in Phase-2-ENACT-Studie | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.29% | -7.59% | +3.08% | -55.33% | -51.45% | -77.67% | -94.17% | -96.93% | - | 4.42 Mio. | |
| +1.42% | -5.08% | +5.98% | +9.40% | +1.52% | -4.31% | +12.46% | -22.62% | +201.32% | 46.06 Mrd. | |
| -0.14% | -0.76% | +10.39% | +29.35% | +129.79% | +378.26% | +583.71% | +538.40% | - | 38.91 Mrd. | |
| +0.39% | +2.79% | +17.71% | +2.41% | +5.31% | +8.23% | +61.99% | -0.56% | +1’071.90% | 35.57 Mrd. | |
| -1.54% | -4.01% | +18.30% | +13.30% | -11.93% | +5.95% | -13.03% | -18.94% | +168.16% | 33.13 Mrd. | |
| -0.87% | -3.19% | +0.95% | -12.45% | -1.32% | -1.27% | +29.16% | -23.23% | +132.08% | 26.42 Mrd. | |
| -1.28% | -6.20% | +10.50% | +9.04% | - | - | - | - | - | 16.61 Mrd. | |
| -0.67% | -0.21% | +15.90% | +3.87% | -5.97% | +10.55% | +115.31% | +193.22% | - | 15.08 Mrd. | |
| -5.64% | -4.14% | +2.12% | +7.45% | +6.76% | +5.15% | +8.86% | -35.26% | +94.97% | 14.08 Mrd. | |
| +0.40% | -2.79% | +18.87% | +44.92% | -8.20% | +3.58% | -31.98% | -20.15% | +131.88% | 12.81 Mrd. | |
| -1.91% | -5.11% | +32.17% | +15.57% | -5.98% | +108.47% | +544.65% | +261.08% | +2’640.92% | 11.35 Mrd. | |
| +0.21% | +0.42% | +29.08% | +22.53% | +22.05% | +35.13% | -19.73% | -38.80% | +159.25% | 11.19 Mrd. | |
| -0.32% | -4.17% | +20.46% | +18.34% | +9.64% | +33.88% | +5.97% | -44.39% | +152.02% | 10.53 Mrd. | |
| -0.09% | -0.16% | +1.15% | +47.86% | +77.64% | +238.59% | +557.25% | - | - | 10.07 Mrd. | |
| +1.02% | -1.34% | +67.98% | +30.62% | +39.85% | +52.81% | +57.57% | -56.06% | - | 9.77 Mrd. | |
| -2.67% | -3.31% | +10.95% | +24.30% | +41.81% | +141.13% | +409.89% | +92.30% | - | 9.08 Mrd. | |
| -2.08% | -0.01% | +17.74% | +28.32% | +55.07% | +146.30% | +577.20% | +189.28% | - | 8.71 Mrd. | |
| -1.82% | -1.98% | +2.87% | -7.47% | +5.89% | +463.26% | +1’826.54% | +20.27% | - | 8.7 Mrd. | |
| +1.16% | -1.32% | -28.83% | -27.82% | -31.73% | +28.75% | +32.87% | +44.07% | +94.00% | 8.93 Mrd. | |
| -0.51% | +1.15% | +14.25% | +55.84% | +87.92% | +94.52% | +64.72% | +117.72% | +5.58% | 8.76 Mrd. | |
| Durchschnitt | -0.60% | -1.94% | +13.58% | +13.00% | +19.30% | +87.96% | +248.91% | +61.08% | +441.10% | 16.79 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.49% | -2.18% | +12.97% | +14.02% | +23.90% | +87.18% | +203.61% | +85.44% | +428.37% |
- Börse
- Aktien
- A2P9GM Aktie
- Sektor EXACT Therapeutics
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
